Receive Oncology Imaging Updates from Novartis, GSK and Roche Diagnostics | Oncology Imaging for Drug Development

Share Article

SMi's 10th annual Oncology Imaging for Drug Development, taking place on the 12-13 March in London, will provide comprehensive insights into the usage of imaging in clinical trials, giving delegates access to the latest information, legislation and case studies across the industry.

SMi's Oncology Imaging Conference

SMi's Oncology Imaging Conference

Cancer imaging is set to receive a major boost from a £35 million nationwide initiative to develop cutting-edge imaging technologies for basic and clinical cancer research. Over the next five years funding will be committed to four separate cancer imaging centres across the UK. This latest funding will bring together scientists, engineers and clinicians to develop new imaging techniques and applications which will help clinicians learn more about how tumours feed and grow, how cancer cells signal to one another, tumour blood and the environment surrounding tumours and molecular and genetic signatures.
(Source: The University of Manchester, Cancer Imaging Centres get £35million boost, 24 October 2013)

SMi's 10th annual Oncology Imaging for Drug Development conference will provide a comprehensive insight into the industry and its future. The event will be considering the current landscape of personalised imaging within the field of oncology, as research suggests healthcare that is inherently more ‘personal’ is the way forward. In addition, this year’s event will explore current and future legislation and its impact on imaging. The use of imaging in clinical trials will also be examined and discussed together with the use of novel biomarkers.

2014's Event Highlights Include:

  •     Examine the challenges of multicentre imaging studies
  •     Two new sessions on audit methodologies and the central review from Perceptive Informatics and the US National Institute of Health
  •     Discuss case studies, challenges and opportunities in imaging guidelines featuring Novartis and GSK
  •     Gain an in-depth insight into the challenges of imaging in Europe
  •     Evaluate the value of imaging strategically

Speaker Panel Includes:

  •     Werner Scheuer, Research Leader Preclinical Imaging, Roche Diagnostics
  •     Lori Dodd, PhD, Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, US National Institutes of Health
  •     Dr Marijn Vlaming, Research Scientist, TNO
  •     Prash Krishna, Global Clinical Leader - Oncology, Novartis
  •     Pallavi Chaturvedi, Imaging Project Manager, GSK Vesalius Imaging
  •     Francois Lassailly, Head of in Vivo Imaging, Cancer Research UK
  •     Dr Malcom Barratt-Johnson, Managing Director, PharmaMedic Consultancy

Don’t miss the pre-conference workshop on
Pharmacokinetics
11th March 2014, 08:30am-12:30pm | London, UK
Led by Dr Marijn Vlaming, Research Scientist, TNO

To view the full speaker line-up and conference programme, visit http://www.smi-online.co.uk/2014cancer-imaging27.asp.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sonal Patel

Sonal Patel
SMi Group Ltd
+44-207-827-6106
Email >
Visit website